Sonodynamic Therapy Inhibits Fibrogenesis in Rat Cardiac Fibroblasts Induced by TGF-β1

Cellular Physiology and Biochemistry

Volumn 40, Issue 3-4, 2016, Pages 579-588

  Guo, Yuanyuan ^a,d   Dong, Zengxiang ^a   Shi, Yuanqi ^a   Wang, Wei ^a   Wang, Lu ^a   Sun, Jing ^b   Sun, Xin ^a   Tian, Zhen ^b   Yao, Jianting ^a   Li, Zhitao ^b   Cheng, Jiali ^a   Tian, Ye ^a,b,c  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Biopharmaceutical Institute   (China)

^d THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

AKT; Cardiac fibroblast; GSK3 ; SDT; TGF 1

Indexed keywords

AMINOLEVULINIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN; PROTEIN KINASE B; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROGENESIS; HEART FIBROBLAST; IN VITRO STUDY; INTRACELLULAR SIGNALING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SONODYNAMIC THERAPY; ULTRASOUND THERAPY; UPREGULATION; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; CELL CYCLE; CELL DEATH; CELL SURVIVAL; DRUG EFFECTS; FIBROBLAST; FIBROSIS; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; TRANSFORMED CELL LINE; ULTRASOUND;

AMINOLEVULINIC ACID; ANIMALS; ANIMALS, NEWBORN; CELL CYCLE; CELL DEATH; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN; FIBROBLASTS; FIBROSIS; GLYCOGEN SYNTHASE KINASE 3 BETA; INTRACELLULAR SPACE; MYOCARDIUM; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTOPORPHYRINS; RATS, SPRAGUE-DAWLEY; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ULTRASONICS;

EID: 85000925692     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000452571     Document Type: Article

References (29)

1. Long CS, Brown RD: The cardiac fibroblast, another therapeutic target for mending the broken heart J Mol Cell Cardiol 2002;34:1273-1278.
2. Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC: Cardiac Fibrosis: The Fibroblast Awakens. Circ Res 2016;118:1021-1040.
3. Camelliti P, Green CR, Kohl P: Structural and functional coupling of cardiac myocytes and fibroblasts. Adv Cardiol 2006;42:132-149.
4. Souders CA, Bowers SL, Baudino TA: Cardiac fibroblast: the renaissance cell. Circ Res 2009;105:1164-1176.
5. Porter KE, Turner NA: Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther 2009;123:255-278.
6. Moore-Morris T, Guimarães-Camboa N, Yutzey KE, Pucéat M, Evans SM: Cardiac fibroblasts: from development to heart failure. J Mol Med (Berl) 2015;93:823-830.
7. Gary R, Davis L: Diastolic heart failure. Heart Lung 2008;37:405-416.
8. Ali SR, Ranjbarvaziri S, Talkhabi M, Zhao P, Subat A, Hojjat A, Kamran P, Müller AM, Volz KS, Tang Z, Red-Horse K, Ardehali R: Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ Res 2014;115:625-635.
9. Leask A: TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 2007;74:207-212.
10. Yumita N, Nishigaki R, Umemura K, Umemura S: Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res 1989;80:219-222.
11. Trendowski M: The promise of sonodynamic therapy. Cancer Metastasis Rev 2014;33:143-160.
12. Gao Q, Wang F, Guo S, Li J, Zhu B, Cheng J, Jin Y, Li B, Wang H, Shi S, Gao Q, Zhang Z, Cao W, Tian Y: Sonodynamic effect of an anti-inflammatory agent-emodin on macrophages. Ultrasound Med Biol 2011;37:1478-1485.
13. Guo S, Sun X, Cheng J, Xu H, Dan J, Shen J, Zhou Q, Zhang Y, Meng L, Cao W, Tian Y: Apoptosis of THP-1 macrophages induced by protoporphyrin IX-mediated sonodynamic therapy. Int J Nanomed 2013;8:2239-2246.
14. Zheng L, Sun X, Zhu X, Lv F, Zhong Z, Zhang F, Guo W, Cao W, Yang L, Tian Y: Apoptosis of THP-1 derived macrophages induced by sonodynamic therapy using a new sonosensitizer hydroxyl acetylated curcumin. PLoS One 2014;9:e93133
15. Bell KF, Al-Mubarak B, Fowler JH, Baxter PS, Gupta K, Tsujita T, Chowdhry S, Patani R, Chandran S, Horsburgh K, Hayes JD, Hardingham GE: Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci USA 2011;108:E1-2.
16. Victorino VJ, Mencalha AL, Panis C: Post-translational modifications disclose a dual role for redox stress in cardiovascular pathophysiology. Life Sci 2015;129:42-47.
17. Lu HS, Chen HP, Wang S, Yu HH, Huang XS, Huang QR, He M: Hypoxic preconditioning up-regulates DJ-1 protein expression in rat heart-derived H9c2 cells through the activation of extracellular-regulated kinase 1/2 pathway. Mol Cell Biochem 2012;370:231-240.
18. Zhang K, He X, Zhou Y, Gao L, Qi Z, Chen J, Gao X: Atorvastatin Ameliorates Radiation-Induced Cardiac Fibrosis in Rats. Radiat Res 2015;184:611-620.
19. Xiong W, Wang P, Hu J, Jia Y, Wu L, Chen X, Liu Q, Wang X: A new sensitizer DVDMS combined with multiple focused ultrasound treatments: An effective antitumor strategy. Sci Rep 2015;5:17485.
20. Costley D, Mc Ewan C, Fowley C, McHale AP, Atchison J, Nomikou N, Callan JF: Treating cancer with sonodynamic therapy: A review. Int J Hyperthermia 2015;31:107-117.
21. Li C, Zhang K, Wang P, Hu J, Liu Q, Wang X: Sonodynamic antitumor effect of a novel sonosensitizer on S180 solid tumor. Biopharm Drug Dispos 2014;35:50-59.
22. Arakawa K, Hagisawa K, Kusano H, Yoneyama S, Kurita A, Arai T, Kikuchi M, Sakata I, Umenura Si S, Ohsuzu F: Sonodynamic therapy decreased neointimal hyperplasia after stenting in the rabbit iliac artery. Circulation 2002;105:149-151.
23. Cheng J, Sun X, Guo S, Cao W, Chen H, Jin Y, Li B, Li Q, Wang H, Wang Z, Zhou Q, Wang P, Zhang Z, Cao W, Tian Y: Effects of 5-aminolevulinic acid-mediated sonodynamic therapy on macrophages. Int J Nanomedicine 2013;8:669-676.
24. Lal H, Ahmad F, Zhou J, Yu JE, Vagnozzi RJ, Guo Y, Yu D, Tsai EJ, Woodgett J, Gao E, Force T. Cardiac Fibroblast Glycogen Synthase Kinase-3 Regulates Ventricular Remodeling and Dysfunction in Ischemic Heart. Circulation 2014;130:419-430.
25. Zhou J, Ahmad F, Parikh S, Hoffman NE, Rajan S, Verma VK, Song J, Yuan A, Shanmughapriya S, Guo Y, Gao E, Koch W, Woodgett JR, Madesh M, Kishore R, Lal H, Force T: Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy. Circ Res 2016;118:1208-1222.
26. Liu X, Liu C, Li J, Zhang X, Song F, Xu J: Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/ GSK-3 signaling pathway. Endocr Res 2016;2:1-8.
27. MacAulay K, Woodgett JR: Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of type 2 diabetes. Expert Opin Ther Targets 2008;12:1265-1274.
28. Forde JE, Dale TC: Glycogen synthase kinase 3: A key regulator of cellular fate. Cell Mol Life Sci 2007;64:1930-1944.
29. Doble BW, Woodgett JR: GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003;116:1175-1186.